The name change touches on the company’s AI and machine learning proficiencies, while including the expansion of the company’s mission to serve additional regulated industries including animal health, cosmetics, medical devices, specialty chemicals, nutraceuticals, and food and beverage.
Bigfinite, an artificial intelligence (AI) and advanced analytics platform company, announced on Oct. 5, 2020 that it is changing its name to Aizon to highlight its capabilities and expansion of its mission plan.
According to a company press release, the name change touches on the company’s AI and machine learning proficiencies while including the expansion of the company’s mission to serve additional regulated industries, including animal health, cosmetics, medical devices, specialty chemicals, nutraceuticals, and food and beverage.
“This is a symbol of change, not a change of symbol. Markets are increasingly in need of advanced artificial intelligence, flexible [Internet of things] data acquisition, compliant data lakes, deep learning, and other industrial-grade technologies,” said John Vitalie, CEO of Aizon, in the press release. “Aizon is well positioned to help those manufacturing sectors meet stringent regulatory requirements and extract deeper understanding of complex processes, which ultimately leads to new sources of value. This is especially critical as the demand to scale production with even more efficiency increases—as we see with pharma and other regulated industries.”
Source: Aizon
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.